
LongWater Opportunities Launches Private Credit and Capital Solutions Strategy
Strategy to Be Led by Highly Successful Eight-Person Team With Expertise in Private Credit, and Equity Co-Investment and Primary LP Equity Commitments to GPs Significantly... Read more.

Global Respiratory Care Medical Devices Market Set to Reach US$24.08 Billion by 2023, Fueled by Rising Incidence of Respiratory Disorders and Technological Advancements – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Respiratory Care Medical Devices Market (by Disorder, Product Type, End User, & Region): Insights and Forecast... Read more.

Lazard Declares Quarterly Dividend of $0.50 Per Share
NEW YORK–(BUSINESS WIRE)–Lazard Ltd (NYSE: LAZ) today announced that its Board of Directors has voted to declare a quarterly dividend of $0.50 per share... Read more.

Hummingbird Diagnostics GmbH to Unveil Pioneering Alzheimer’s Disease Biomarker Research at CTAD Conference
HEIDELBERG, Germany–(BUSINESS WIRE)–Hummingbird Diagnostics GmbH, a leader in blood-based small RNA detection and characterization, today announced the... Read more.

Giving Agents Financial Freedom Takes Center Stage at the Real RISE 2023 Conference
Real empowers agent success with revenue-sharing post-retirement; unveils wealth-building tools and longer term vision of the “Real Wallet” that provides rewards... Read more.

Cybin Announces Grant of Two New United States Patents Protecting its Deuterated DMT Program
– New United States patent grants offer protection for deuterated analogs of DMT including composition of matter, medical use and synthesis – –... Read more.

Hess Reports Estimated Results for the Third Quarter of 2023
Key Development: On October 23rd the Corporation entered into an agreement to merge with Chevron. The transaction is expected to close in the first half of 2024... Read more.

Monro, Inc. Announces Second Quarter Fiscal 2024 Financial Results
Second Quarter Sales Decreased to $322.1 Million Second Quarter Comparable Store Sales Decreased 2.3% Second Quarter Diluted EPS of $.40; Adjusted Diluted EPS1 of... Read more.

Fortive Reports Strong Third Quarter 2023 Results; Narrows Full Year 2023 Outlook
Q3 revenue growth of 2.6%, 2.5% core, reflecting growth in all segments Software businesses demonstrating resilience with annual recurring revenue growth of 9% Operating... Read more.

NOG Provides Preliminary Financial and Operational Updates for the Third Quarter of 2023
HIGHLIGHTS Strong organic and Ground Game activity driving additional development Q3 Ground Game transactions expected to add 5.7 net in-process and future drilling... Read more.